Browsing: Targets

CJ Chairman Lee Jae-hyun, right, visits CJ Olive Young’s first U.S. store in Pasadena, Calif., May 31. Courtesy of CJ Group

A nationwide recall is affecting two popular frozen desserts sold under the Reese’s and Almond Joy brand names, prompting shoppers to take another look at what is in their freezers

|| CJ Chairman Lee Jay-hyun tastes mini wontons and kimchi ramen at the Bibigo booth during a visit to KCON LA 2026. Photo courtesy of CJ CJ Chairman Lee Jay-hyun tours the Olive Young Festa during a visit to KCON LA 2026. Photo courtesy of CJ

Mahindra is targeting a more than doubling of India’s lifestyle pick-up market to close to 10,000 units annually over the next few years from roughly 4,000-4,500 units now, as it prepares to launch the Scorpio Lifestyler by April 2027 at a starting price below ₹19.79 lakh, substantially undercutting the Toyota Hilux

SAN FRANCISCO, California: Eli Lilly has filed lawsuits against six U.S. companies it accuses of illegally selling black-market versions of its experimental obesity drug retatrutide, stepping up action against unauthorized sellers before the medicine has received regulatory approval

BioMarin PharmaceuticalNASDAQ: BMRN outlined its growth strategy, integration plans for Amicus Therapeutics and pipeline priorities during a Canaccord discussion with Chief Financial Officer Brian Mueller

Pearl Jam frontman Eddie Vedder is backing Rare Ventures, a Pittsburgh-based start-up created to find cures for rare diseases. (Louis B. Ruediger | TribLive)

Eli Lilly and Co. (LLY, Financials), the pharmaceutical company behind Zepbound and Foundayo, is stepping up its fight against unauthorized sellers of its experimental obesity drug retatrutide

Core business stabilization: AirSculpt reported positive case growth for the past two quarters after several periods of decline. Management expects third-quarter same-store sales to fall by a single-digit percentage but forecasts full-year sales to be roughly flat to slightly higher

MISSOULA – Missoula pediatrician Laurie Carter is piloting a program with University of Montana researchers as part of RESOLVE, a new strategic healthcare partnership between UM and Providence Health